Nasdaq
$74.73▲ 0.08%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $2.85BShares out 38.2M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
49- 2d agoAfter-hours26.10.23 06:118-KKey event#●●●#●●●#●●●
Disc Medicine, Inc.
Disc Medicine has raised $450 million in gross proceeds through an underwritten public offering of 6 million shares of common stock at a price of $75.00 per share. The offering closed on October 22, 2026, and the proceeds will be used to fund research, clinical development, and pre-commercialization activities for its product candidates, including bitopertin.…more
$74.73+0.08%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 3d agoAfter-hours26.10.22 06:334Ownership
Disc Medicine, Inc.
Insider Kevin Bitterman of Disc Medicine, Inc. has filed a Form 4 report regarding a change in beneficial ownership of company securities as of October 19, 2026. This filing serves as an official notification of the insider's updated stock holdings.…more
$74.73+0.08%vs prev closeView filingShare - 3d agoAfter-hours26.10.22 06:21424B5Offering
Disc Medicine, Inc.
Disc Medicine, Inc. is conducting a public offering of 6,000,000 shares of its common stock at a price of $75.00 per share, raising $450 million in gross proceeds. The underwriters have been granted a 30-day option to purchase up to an additional 900,000 shares.…more
$74.73+0.08%vs prev closeView filingShare
48 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 4d agoOvernight26.10.21 09:52Bullish#●●●#●●●#●●●
Disc Medicine Prices $450 Million Upsized Public Offering
Disc Medicine has priced an upsized public offering of common stock to raise approximately $450 million. The proceeds will be used to fund research, clinical development, and commercialization activities for its product pipeline.…more
$74.73+0.08%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 5d agoAfter-hours26.10.20 05:01
●●●●●●●● ●●●●● ●●●●●●
Disc Medicine has announced a proposed $350 million public offering of common stock and pre-funded warrants to fund clinical development and commercialization efforts. The offering will result in equity dilution for existing shareholders.…more
$74.73+0.08%vs prev close - 5d agoRegular26.10.20 01:33
●●●●●●●● ●●●●● ●●●●●●
Disc Medicine's bitopertin successfully met all primary and secondary endpoints in its Phase 3 trial for erythropoietic protoporphyria. The company plans to resubmit a new drug application to the FDA by the end of the year.…more
$74.73+0.08%vs prev closeShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report